Antibacterial drugs and the risk of community-associated methicillin-resistant Staphylococcus aureus in children

Archives of Pediatrics and Adolescent Medicine

Volumn 165, Issue 12, 2011, Pages 1107-1114

  Schneider Lindner, Verena ^a,b   Quach, Caroline ^b,c   Hanley, James A ^b   Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLOXACILLIN; MACROLIDE; PENICILLIN G; PENICILLINASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DRUG PRESCRIPTIONS; FEMALE; GREAT BRITAIN; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 83055171451     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.143     Document Type: Article

References (39)

1. Fridkin SK, Hageman JC, Morrison M, et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444.
2. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(suppl 5):S344-S349. (Pubitemid 351717321)
3. Elston JW, Barlow GD. Community-associated MRSA in the United Kingdom. J Infect. 2009;59(3):149-155.
4. Otter JA, French GL. Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis. 2010;10(4):227-239.
5. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557-1568.
6. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593-598. (Pubitemid 28110205)
7. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144(5):309-317. (Pubitemid 46768185)
8. Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(5):752-760. (Pubitemid 351321562)
9. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785-1791. (Pubitemid 40799948)
10. Zaoutis TE, Toltzis P, Chu J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J. 2006;25(4):343-348.
11. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41(5):583-590. (Pubitemid 41170343)
12. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. JAMA. 1999;282(12):1123-1125.
13. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL; Toronto Child Care Center Study Group. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med. 1999;153(8):864-868. (Pubitemid 29362613)
14. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis. 1998;178(2):577-580. (Pubitemid 28347950)
15. Rihn JA, Posfay-Barbe K, Harner CD, et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team: unsuccessful interventions. Pediatr Infect Dis J. 2005;24(9):841-843. (Pubitemid 41324899)
16. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 1998;158(8):895-899. (Pubitemid 28183645)
17. Begier EM, Frenette K, Barrett NL, et al. Connecticut Bioterrorism Field Epidemiology Response Team. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39(10):1446-1453. (Pubitemid 39518207)
18. Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11(4):526-532. (Pubitemid 40462900)
19. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis. 2008;46(11):1637-1646. (Pubitemid 351706759)
20. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg. 2010;45(10):1967-1974.
21. Schneider-Lindner V, Delaney JA, Dial S, Dascal A, Suissa S. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis. 2007;13(7):994-1000. (Pubitemid 47048069)
22. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis. 2004;189(9):1565-1573. (Pubitemid 38648283)
23. General Practice Research Database . http://www.gprd.com/home/. Accessed June 15, 2011.
24. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350(9084):1097-1099. (Pubitemid 27437871)
25. Lawrenson R, Williams T, Farmer R. Clinical information for research: the use of general practice databases. J Public Health Med. 1999;21(3):299-304. (Pubitemid 29446069)
26. Frischer M, Heatlie H, Norwood J, Bashford J, Millson D, Chapman S. Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997. J Public Health Med. 2001;23(1):69-73. (Pubitemid 32246305)
27. Wrigley T, Tinto A, Majeed A. Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales, 1994 to 1998. Health Stat Q. 2002;14:14-20.
28. Smith GE, Smith S, Heatlie H, et al. What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? description of trends in antimicrobial usage using the General Practice Research Database. J Public Health (Oxf) . 2004;26(4):359-364. (Pubitemid 40070453)
29. Schneider-Lindner V, Quach C, Hanley JA, Suissa S. Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother. 2011;66(2):424-433.
30. Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother. 2001;48(6):895-901. (Pubitemid 33735327)
31. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989-2995. (Pubitemid 41817660)
32. Delaney JA, Schneider-Lindner V, Brassard P, Suissa S. Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med. 2008;6:2.
33. Chisholm J. The Read clinical classification. BMJ. 1990;300(6732):1092. (Pubitemid 20158094)
34. Perry J, ed. OXMIS Problem Codes for Primary Medical Care. Oxford, England: Headington; 1978.
35. Feinstein AR, Horwitz RI. An algebraic analysis of biases due to exclusion, susceptibility, and protopathic prescription in case-control research. J Chronic Dis. 1981;34(8):393-403. (Pubitemid 11059653)
36. Joint Formulary Committee. British National Formulary. 59th ed. London, England: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2010.
37. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488-495.
38. Bratu S, Eramo A, Kopec R, et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis. 2005;11(6):808-813. (Pubitemid 40720839)
39. Nguyen DM, Bancroft E, Mascola L, Guevara R, Yasuda L. Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery. Infect Control Hosp Epidemiol. 2007;28(4):406-411. (Pubitemid 46658052)